Literature DB >> 31646686

Commentary on Barbosa et al. (2019): The value of using community simulation modeling to achieve HCV elimination targets in people who inject drugs.

Bruce R Schackman1, Zachary F Meisel2,3.   

Abstract

Entities:  

Keywords:  Cost-effectiveness; elimination; hepatitis C; implementation; people who inject drugs; simulation model

Mesh：

Year:  2019        PMID： 31646686      PMCID： PMC6868309          DOI： 10.1111/add.14807

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  6 in total

Review 1.  Researchers and policymakers: travelers in parallel universes.

Authors:  Ross C Brownson; Charles Royer; Reid Ewing; Timothy D McBride
Journal:  Am J Prev Med       Date:  2006-02       Impact factor: 5.043

2.  Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.

Authors:  Suerie Moon; Elise Erickson
Journal:  N Engl J Med       Date:  2019-02-14       Impact factor: 91.245

3.  Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.

Authors:  Jisoo A Kwon; Gregory J Dore; Jason Grebely; Behzad Hajarizadeh; Rebecca Guy; Evan B Cunningham; Cherie Power; Chris Estes; Homie Razavi; Richard T Gray
Journal:  J Viral Hepat       Date:  2018-11-14       Impact factor: 3.728

4.  Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.

Authors:  Carolina Barbosa; Hannah Fraser; Thomas J Hoerger; Alyssa Leib; Jennifer R Havens; April Young; Alex Kral; Kimberly Page; Jennifer Evans; Jon Zibbell; Susan Hariri; Claudia Vellozzi; Lina Nerlander; John W Ward; Peter Vickerman
Journal:  Addiction       Date:  2019-08-02       Impact factor: 6.526

5.  Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.

Authors:  Kiren Mitruka; Tengiz Tsertsvadze; Maia Butsashvili; Amiran Gamkrelidze; Paata Sabelashvili; Ekaterine Adamia; Mari Chokheli; Jan Drobeniuc; Liesl Hagan; Aaron M Harris; Tea Jiqia; Ana Kasradze; Stephen Ko; Vakhtang Qerashvili; Lali Sharvadze; Irina Tskhomelidze; Valeri Kvaratskhelia; Juliette Morgan; John W Ward; Francisco Averhoff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-24       Impact factor: 17.586

6.  Strengthening partnerships between substance use researchers and policy makers to take advantage of a window of opportunity.

Authors:  Zachary F Meisel; Julia Mitchell; Daniel Polsky; Nada Boualam; Ellen McGeoch; Janet Weiner; Matthew Miclette; Jonathan Purtle; Bruce Schackman; Carolyn C Cannuscio
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.